Taspase 1: A protease with many biological surprises

Hidetaka Niizuma; Emily H. Cheng; James J. Hsieh

doi:10.1080/23723556.2014.999513

Taspase 1: A protease with many biological surprises

Hidetaka Niizuma
, Emily H. Cheng
, James J. Hsieh

Research output: Contribution to journal › Article › peer-review

21 Scopus citations

Abstract

Taspase 1 (TASP1) cleaves the mixed-lineage leukemia (MLL) and transcription factor (TF) IIA families of nuclear proteins to orchestrate various biological processes. TASP1 is not a classical oncogene, but assists in cell proliferation and permits oncogenic initiation through cleavage of MLL and TFIIA. TASP1 is thus better classified as a “non-oncogene addiction” protease, and targeting TASP1 offers a novel and attractive anticancer therapeutic strategy.

Original language	English
Article number	e999513
Journal	Molecular and Cellular Oncology
Volume	2
Issue number	4
DOIs	https://doi.org/10.1080/23723556.2014.999513
State	Published - Oct 2 2015

Keywords

CDK inhibitor
MLL
TFIIA
Taspase 1
cyclin

Access to Document

10.1080/23723556.2014.999513

Cite this

@article{d59484621e85432881b516eff9dff9dd,

title = "Taspase 1: A protease with many biological surprises",

abstract = "Taspase 1 (TASP1) cleaves the mixed-lineage leukemia (MLL) and transcription factor (TF) IIA families of nuclear proteins to orchestrate various biological processes. TASP1 is not a classical oncogene, but assists in cell proliferation and permits oncogenic initiation through cleavage of MLL and TFIIA. TASP1 is thus better classified as a “non-oncogene addiction” protease, and targeting TASP1 offers a novel and attractive anticancer therapeutic strategy.",

keywords = "CDK inhibitor, MLL, TFIIA, Taspase 1, cyclin",

author = "Hidetaka Niizuma and Cheng, \{Emily H.\} and Hsieh, \{James J.\}",

note = "Publisher Copyright: {\textcopyright} 2015, {\textcopyright} 2015 The Author(s). Published with license by Taylor \& Francis Group, LLC. {\textcopyright} 2015, {\textcopyright} Hidetaka Niizuma, Emily H Cheng, and James J Hsieh.",

year = "2015",

month = oct,

day = "2",

doi = "10.1080/23723556.2014.999513",

language = "English",

volume = "2",

journal = "Molecular and Cellular Oncology",

issn = "2372-3556",

number = "4",

}

TY - JOUR

T1 - Taspase 1

T2 - A protease with many biological surprises

AU - Niizuma, Hidetaka

AU - Cheng, Emily H.

AU - Hsieh, James J.

PY - 2015/10/2

Y1 - 2015/10/2

N2 - Taspase 1 (TASP1) cleaves the mixed-lineage leukemia (MLL) and transcription factor (TF) IIA families of nuclear proteins to orchestrate various biological processes. TASP1 is not a classical oncogene, but assists in cell proliferation and permits oncogenic initiation through cleavage of MLL and TFIIA. TASP1 is thus better classified as a “non-oncogene addiction” protease, and targeting TASP1 offers a novel and attractive anticancer therapeutic strategy.

AB - Taspase 1 (TASP1) cleaves the mixed-lineage leukemia (MLL) and transcription factor (TF) IIA families of nuclear proteins to orchestrate various biological processes. TASP1 is not a classical oncogene, but assists in cell proliferation and permits oncogenic initiation through cleavage of MLL and TFIIA. TASP1 is thus better classified as a “non-oncogene addiction” protease, and targeting TASP1 offers a novel and attractive anticancer therapeutic strategy.

KW - CDK inhibitor

KW - MLL

KW - TFIIA

KW - Taspase 1

KW - cyclin

UR - https://www.scopus.com/pages/publications/85046638385

U2 - 10.1080/23723556.2014.999513

DO - 10.1080/23723556.2014.999513

M3 - Article

C2 - 27308523

AN - SCOPUS:85046638385

SN - 2372-3556

VL - 2

JO - Molecular and Cellular Oncology

JF - Molecular and Cellular Oncology

IS - 4

M1 - e999513

ER -

Taspase 1: A protease with many biological surprises

Abstract

Keywords

Access to Document

Other files and links

Fingerprint

Cite this